课题基金 / 基金详情

DNA repair defect, tumorigensis, and hereditary breast cancer gene Brca2 -Studies in vitro and in vivo, and association with Rad51.

DNA repair defect, tumorigensis, and hereditary breast cancer gene Brca2 -Studies in vitro and in vivo, and association with Rad51.
DNA 修复缺陷、肿瘤发生和遗传性乳腺癌基因 Brca2 - 体外和体内研究以及与 Rad51 的关联。
批准号:
11460133
负责人:
MORIMATSU Masami
金额:
$8.32万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2001

项目摘要

项目成果

MORIMATSU Masami的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
To establish the bases of developing new methods for prevention, diagnosis, and therapy of breast cancer , we investigated in vitro and invivo functions of the Brca2 and other tumor associated genes. Especially, researches for the significance of the interaction of Brca2 and Rad51, application of Brca2 analysis in veterinary medicine, and roles IkB MAIL were carried out.1. Cloning and mutation analysis of canine Brca2Full length (about 10 kbp) of the cDNA for canine Brca2 was cloned and sequenced. For mutation analysis, DNA fragments were obtained by PCR and used for protein truncation tests.2. Cloning and expression of feline Brca2Full length (about 10 kbp) of the cDNA for feline Brca2 was cloned and sequenced. Expression of feline Brca2 was confirmed in mamnary gland.3. Interaction of Brca2 and Rad51Interaction of C-terminus of canine Brca2 with Rad51 was demonstrated by yeast two-hybrid assay. Transactivation activity of canine Brca2 was also demonstrated.4. Characterization of a novel IkB protein, MAILWe cloned, sequenced, and analyzed the expression of the MAIL gene encoding a novel IkB protein.
期刊论文(44)
专著(0)
科研奖励(0)
会议论文
Iwasaki, K.: "Isolation, characterization, and cDNA cloning of chicken turpentine-induced protein, a new member of the scavenger receptor cystein-rich (SRCR) family of proteins"J. Biol. Chem.. 276. 9400-9405 (2001)
Iwasaki, K.:“鸡松节油诱导蛋白的分离、表征和 cDNA 克隆,该蛋白是清道夫受体富含半胱氨酸 (SRCR) 蛋白家族的新成员”J.
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kitamura, H.: "MAIL, a novel nuclear IkB protein that potentiates LPS-induced IL-6 production"FEBS Lett.. 485. 53-56 (2000)
Kitamura, H.:“MAIL,一种新型核 IkB 蛋白,可增强 LPS 诱导的 IL-6 产生”FEBS Lett.. 485. 53-56 (2000)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Nawa,A., et al.: "Tumor metastasis-associated human MTA1 gene : its deduced protein sequence, localization, and association with breast cancer cell proliferation using antisense phosphorothioate oligonucleotides"J Cell Biochem.. 79. 202-212 (2000)
Nawa,A., et al.:“肿瘤转移相关的人 MTA1 基因:使用反义硫代磷酸寡核苷酸推导的蛋白质序列、定位以及与乳腺癌细胞增殖的关联”J Cell Biochem.. 79. 202-212 (2000)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kitamura, H.: "Bacterial lipopolysaccharide induced mRNA expression of a IkB MAIL mediated through Toll-like receptor 4"J. Vet. Med. Sci. (印刷中).
Kitamura, H.:“细菌脂多糖通过 Toll 样受体 4 介导的 IkB MAIL 的 mRNA 表达”J. Vet。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
21
    Tumorigenic effects of BRCA2 mutation and genomic instability in dogs
    • 批准号:
      23580399
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.49万
    • 财政年份:
      2011
    • 负责人:
      MORIMATSU Masami
    • 依托单位:
    Analysis of a novel NFkB inhibitor deficient mouse as a model for atopic dermatisis
    • 批准号:
      19380164
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.65万
    • 财政年份:
      2007
    • 负责人:
      MORIMATSU Masami
    • 依托单位:
    Regulation of host defense and development by innate-immunity signal transduction system
    Study for the development of new gene targeting method utilizing epitope tags
    • 批准号:
      11556064
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $7.23万
    • 财政年份:
      1999
    • 负责人:
      MORIMATSU Masami
    • 依托单位:
    国内基金
    海外基金
    外周犬尿氨酸通过脑膜免疫致海马BDNF水平降低介导术后认知功能障碍
    • 批准号:
      82371193
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      苏殿三
    • 依托单位:
    拟南芥ANAC060/AFP2复合体调控DOG1参与种子初始休眠的机理研究
    • 批准号:
      32170562
    • 项目类别:
      面上项目
    • 资助金额:
      58万元
    • 批准年份:
      2021
    • 负责人:
      李平
    • 依托单位:
    抗DOG1抗体偶联α-Amanitin靶向治疗肝癌的研究
    • 批准号:
      81602169
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      17.0万元
    • 批准年份:
      2016
    • 负责人:
      伍洋平
    • 依托单位:
    DOG1基因参与调控刺萼龙葵种子季节性休眠的分子机制